Copyright © 2011
Slone Epidemiology Center
Boston Univeristy


Last Updated:
April 26, 2011



 

  • Mitchell AA, Goldman P, Shapiro S, Slone D. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 1979;110:196-204.
  • Mitchell AA, Rosenberg L, Shapiro S, Slone D. Birth defects related to Bendectin use in pregnancy: 1. Oral clefts and cardiac defects. JAMA 1981;245:2311-14.
  • Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 1986;123:670-6.
  • Lesko SM, Mitchell AA, Epstein MF, Louik C, Giacoia GP, Shapiro S. Heparin use as a risk factor for intraventricular hemorrhage in low-birth-weight infants. N Engl J Med 1986;314:1156-60.
  • Louik C, Mitchell AA, Werler M, Hanson J, Shapiro S. Maternal exposure to spermicides in relation to certain birth defects. N Engl J Med 1987;317:474-8.
  • Lesko SM, Epstein MF, Mitchell AA. Recent patterns of drug use in newborn intensive care. J Pediatr 1990;116:985-90. .
  • Mitchell AA. Teratogens and the dermatologist: New knowledge, responsibilities, and opportunities. [Editorial] Arch Dermatol 1991;127:399-401
  • Werler M, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-61.
  • Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: A practitioner-based randomized clinical trial. JAMA 1995;273:929-33.
  • Mitchell AA, Van Bennekom C, Louik C. A pregnancy-prevention program in women of childbearing age receiving isotretinoin. N Engl J Med 1995;333:101-6.
  • Lesko SM, Corwin MJ, Vezina RM, Hunt CE, Mandell F, McClain M, Heeren T, Mitchell AA. Changes in sleep position during infancy: A prospective longitudinal assessment. JAMA 1998;280:336-40.
  • Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000;343:1608-14.
  • Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001;153:961-8.
  • Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone Survey. JAMA 2002;287:337-44.
  • Mitchell AA. Infertility treatment - More risks and challenges. [Editorial] N Engl J Med 2002;346:769-70.
  • Mitchell AA. Systematic identification of drugs that cause birth defects – A new opportunity. N Engl J Med 2003;349:2556-9.
  • Vernacchio L, Mitchell AA. Chapter 56: Epidemiology of adverse drug effects. In Yaffe and Aranda (editors) Neonatal and Pediatric Pharmacology, Lippincott, Williams, and Wilkins, 3rd Edition, 2005.
  • Mitchell AA. Chapter 32: Studies of Drug-Induced Birth Defect. Pharmacoepidemiology (Strom BL, ed). New York: Wiley, 4 th Edition, 2005.





General Information


Publications



Email: allenmit@bu.edu